Persistent Pain After Heart Attack Linked to Increased Mortality Risk, Comparable to Smoking
New research reveals that ongoing pain a year after a heart attack can significantly increase the risk of premature death, on par with smoking and high blood pressure. The study highlights the importance of recognizing chronic pain as an independent health risk in cardiovascular care.
Recent research highlights that experiencing ongoing pain one year following a heart attack significantly elevates the risk of premature death, with figures comparable to the risks associated with smoking and high blood pressure. Conducted by a team from Dalarna University, Region Dalarna, Karolinska Institutet, and Uppsala University, the study analyzed data from nearly 100,000 patients registered in the SWEDEHEART register, tracking their health outcomes over up to 16 years.
The study found that patients reporting persistent pain one year after a heart attack faced up to a 70% higher chance of mortality compared to those without pain. Notably, this increased risk was evident even among individuals without traditional risk factors like obesity or diabetes, including younger, normal-weight patients and those without chest pain.
Experts emphasize that long-term pain following a heart event should be recognized as a significant risk factor. Historically viewed primarily as a symptom, chronic pain is now being acknowledged as an independent health threat, similar in severity to smoking. This shift in perspective underscores the importance of comprehensive pain management and monitoring as part of post-heart attack care.
The findings are based on a robust data set, building upon earlier smaller studies, and suggest a pressing need for the medical community to include pain assessment in the evaluation of long-term cardiovascular risk. The research underscores the potential for pain management to improve survival outcomes and advocates for turning the scientific focus toward chronic pain as a critical factor in cardiovascular health.
Published in the journal IJC Heart & Vasculature (2025), this study sheds light on the overlooked impact of persistent pain and calls for increased attention to pain as a vital component in cardiac prognosis.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Repurposing Decades-Old Drug Oxybutynin for Mitochondrial Disease Treatment
Researchers have discovered that oxybutynin, a decades-old drug used for bladder disorders, may be repurposed to treat mitochondrial diseases by enhancing cellular energy pathways. This promising research opens new avenues for combating these severe genetic disorders.
Gene 'Switches' Can Be Edited to Modulate Inflammation, Paving the Way for New Therapies
Scientists have successfully manipulated epigenetic marks on immune-related genes using CRISPR technology, opening new possibilities for treating inflammatory diseases and cancer.
Medical Experts Explore Effective Treatments for Newly Identified Genetic Disorder VEXAS
Scientists have discovered VEXAS, a new age-related genetic disorder characterized by immune system inflammation due to acquired mutations in the UBA1 gene. Research is ongoing to develop effective treatments, including immunosuppressants and bone marrow transplants.
Understanding Epigenetic Noise: How Cells Change Identity Through Random Genome Fluctuations
Recent discoveries reveal how random fluctuations in chromatin structure—epigenetic noise—enable cells to change their identity, playing crucial roles in immune tolerance, tissue repair, and cancer development. Learn how cells harness this variability for health and disease.